Double-Edged Enzyme

Researchers find evidence to suggest why an enzyme crucial for fighting off malaria infection is linked to a form of lymphoma.

Aug 13, 2015
Rina Shaikh-Lesko

Burkitt’s lymphomaFLICKR, ED ETHMANActivation-induced cytosine deaminase (AID) is an enzyme critical for protecting against malaria and other infectious diseases. It may also play a key role in triggering Burkitt’s lymphoma, the most common childhood cancer in sub-Saharan Africa, according to a study published today (August 13) in Cell. Although scientists have noted a connection between malaria and Burkitt’s lymphoma for decades, uncovering the biological mechanism behind the association proved elusive. Scientists at Rockefeller University in New York City have now shown that prolonged malaria infection in mice boosts B-lymphocyte and AID production, and that elevated AID likely leads to Burkitt’s lymphoma.

“It’s really groundbreaking for moving the field forward,” said Rosemary Rochford, an immunologist and microbiologist at the University of Colorado, Denver, who was not involved in the research. “This has been a key question in the field for a long time: What’s the role of malaria in promoting Burkitt’s lymphoma?”

Although there was ample epidemiological evidence associating malaria infection with Burkitt’s lymphoma, one challenge was the lack of an animal model to investigate the connection. Rochford noted that the transgenic mice used in the present study fill that gap. “It’s the first animal model that’s been found to demonstrate that Plasmodium infection can promote the development of lymphoma,” she said.

Rockefeller’s Davide Robbiani, Michel Nussenzweig and colleagues infected wild-type mice with Plasmodium chabaudi, causing long-term malaria-like infections in mice. They found that B-lymphocytes had a potent and long-lasting response and that these cells expressed high levels of AID. AID remodels the DNA of antibody genes, a process that is necessary to create the wide array of antibodies produced by B-lymphocytes. But “AID is not a very precise enzyme,” said Robbiani. “It not only does its physiological job, it attacks other regions of DNA in the genome and causes DNA breaks and translocations.”

The researchers then infected two groups of transgenic mice. Both had P53 in their B-lymphocytes knocked out to mimic the human mutation frequently found in Burkitt’s lymphoma. One group of animals showed normal AID function while the other was AID-deficient. The mice that had functional AID all developed lymphomas. Of those that had deficient AID, only about a third developed lymphomas, but they were also much more susceptible to the parasite. “In the absence of AID, the mice were dying of malaria. It shows how crucial the enzyme is to protecting against malaria,” said Robbiani.

Since the mice were not infected with a Plasmodium species that infects humans, more evidence is needed to confirm that AID plays a similar role in the connection between human malaria infection and Burkitt’s lymphoma.

Another complicating factor is that, at least in humans, Epstein-Barr virus (EBV) is also associated with Burkitt’s lymphoma. Further research will be needed to ascertain whether EBV and Plasmodium parasites interact. “The interesting thing would be to start to study how the virus plays into this,” said Karl Munger, a virologist at Tufts University who was not involved in the research. “What EBV does and what Plasmodium does and how these things really interact with each other mechanistically. That’s where I think the money is on this stuff.”

Meanwhile, the results of the present study point to potential clinical applications. Burkitt’s lymphoma affects a relatively narrow age range—children from five to 10 years old. Malaria control programs could exploit this “window of vulnerability to Burkitt’s,” said Kirk Deitsch, a microbiologist at Weil Cornell Medical College in New York City who was not involved in the work. Many young children with chronic malaria are asymptomatic, so doctors might administer prospective treatment.

“If malaria is linked to cancer, it brings malaria control and cancer control together,” said Rochford. “If we drive down malaria through different control methods, we’re going to reduce Burkitt’s lymphoma.”

D. Robbiani et al., “Plasmodium infection promotes genomic instability and AID-dependent B cell lymphoma,” Cell, doi:10.1016/j.cell.2015.07.019, 2015.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets


Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!